Paper1782525
The pathophysiology of acute optic neuritis. An association of gadolinium leakage with clinical and electrophysiological deficits.
Youl BD and 9 others. Brain, 1991. Cited by 227 papers, by iCite.
Cite this record
ConductScience Library. The pathophysiology of acute optic neuritis. An association of gadolinium leakage with clinical and electrophysiological deficits. Papers, record 1782525. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1782525
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The pathophysiology of acute optic neuritis. An association of gadolinium leakage with clinical and electrophysiological deficits.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Optic Neuritis | Major topic |
| Adolescent | |
| Adult | |
| Electrophysiology | |
| Evoked Potentials, Visual | |
| Gadolinium DTPA | |
| Humans | |
| Magnetic Resonance Imaging | |
| Middle Aged | |
| Organometallic Compounds | |
| Pentetic Acid |
Source PubMed
Cited by63
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 227 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41523779 | Ophthalmological manifestations in autoimmune diseases: Overcoming diagnostic and therapeutic challenges. | World J Exp Med | 2025 | https://conductscience.org/library/papers/41523779 | PubMed |
| 40092856 | Visual evoked potentials among Indian patients with optic nerve disorders. | Bioinformation | 2024 | https://conductscience.org/library/papers/40092856 | PubMed |
| 38474322 | Tissue Hypoxia and Associated Innate Immune Factors in Experimental Autoimmune Optic Neuritis. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38474322 | PubMed |
| 38358511 | Analysis of the initial orbital MRI in aquaporin-4 antibody-positive optic neuritis (AQP4-ON): lesion location and lesion length can be predictive of visual prognosis. | Neuroradiology | 2024 | https://conductscience.org/library/papers/38358511 | PubMed |
| 37508003 | Oxidative Stress: A Suitable Therapeutic Target for Optic Nerve Diseases? | Antioxidants (Basel) | 2023 | https://conductscience.org/library/papers/37508003 | PubMed |
| 37402942 | Structure-function relationship between magnetic resonance imaging lesion areas and visual field defects in initial optic neuritis with altitudinal hemianopsia. | Jpn J Ophthalmol | 2023 | https://conductscience.org/library/papers/37402942 | PubMed |
| 36038691 | Optic nerve injury models under varying forces. | Int Ophthalmol | 2023 | https://conductscience.org/library/papers/36038691 | PubMed |
| 35096143 | Smouldering multiple sclerosis: the 'real MS'. | Ther Adv Neurol Disord | 2022 | https://conductscience.org/library/papers/35096143 | PubMed |
| 34943051 | Role of Oxidative Stress in Ocular Diseases Associated with Retinal Ganglion Cells Degeneration. | Antioxidants (Basel) | 2021 | https://conductscience.org/library/papers/34943051 | PubMed |
| 31367861 | Optic nerve sheath diameter: present and future perspectives for neurologists and critical care physicians. | Neurol Sci | 2019 | https://conductscience.org/library/papers/31367861 | PubMed |
| 31193661 | The electrophysiological assessment of visual function in Multiple Sclerosis. | Clin Neurophysiol Pract | 2019 | https://conductscience.org/library/papers/31193661 | PubMed |
| 29731712 | Baseline Brain Activity Changes in Patients With Single and Relapsing Optic Neuritis. | Front Hum Neurosci | 2018 | https://conductscience.org/library/papers/29731712 | PubMed |
| 29507942 | Effect of Treating Acute Optic Neuritis With Bioequivalent Oral vs Intravenous Corticosteroids: A Randomized Clinical Trial. | JAMA Neurol | 2018 | https://conductscience.org/library/papers/29507942 | PubMed |
| 29085182 | Longitudinal Assessment of Transorbital Sonography, Visual Acuity, and Biomarkers for Inflammation and Axonal Injury in Optic Neuritis. | Dis Markers | 2017 | https://conductscience.org/library/papers/29085182 | PubMed |
| 28663263 | How Common Is Signal-Intensity Increase in Optic Nerve Segments on 3D Double Inversion Recovery Sequences in Visually Asymptomatic Patients with Multiple Sclerosis? | AJNR Am J Neuroradiol | 2017 | https://conductscience.org/library/papers/28663263 | PubMed |
| 28539768 | New developments in the treatment of optic neuritis. | Eye Brain | 2010 | https://conductscience.org/library/papers/28539768 | PubMed |
| 28275657 | Utility of coronal contrast-enhanced fat-suppressed FLAIR in the evaluation of optic neuropathy and atrophy. | Eur J Radiol Open | 2017 | https://conductscience.org/library/papers/28275657 | PubMed |
| 28192497 | Optical coherence tomography angiography in eyes with good visual acuity recovery after treatment for optic neuritis. | PLoS One | 2017 | https://conductscience.org/library/papers/28192497 | PubMed |
| 26147975 | Nano-Drugs Based on Nano Sterically Stabilized Liposomes for the Treatment of Inflammatory Neurodegenerative Diseases. | PLoS One | 2015 | https://conductscience.org/library/papers/26147975 | PubMed |
| 26020925 | Parallel changes in structural and functional measures of optic nerve myelination after optic neuritis. | PLoS One | 2015 | https://conductscience.org/library/papers/26020925 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/1782525
GET https://conductscience.org/api/papers/v1/1782525/cited_by?page=2